Synthesis and Evaluation of Novel Analogues of Ripostatins

Ripostatins are polyene macrolactones isolated from the myxobacterium Sorangium cellulosum. They exhibit antibiotic activity by inhibiting bacterial RNA polymerase (RNAP) through a binding site and mechanism that are different from those of current antibacterial drugs. Thus, the ripostatins serve as starting points for the development of new anti‐infective agents with a novel mode of action. In this work, several derivatives of ripostatins were produced. 15‐Desoxyripostatin A was synthesized by using a one‐pot carboalumination/cross‐coupling. 5,6‐Dihydroripostatin A was constructed by utilizing an intramolecular Suzuki cross‐coupling macrolactonization approach. 14,14′‐Difluororipostatin A and both epimeric 14,14′‐difluororipostatins B were synthesized by using a Reformatsky type aldol addition of a haloketone, Stille cross‐coupling, and ring‐closing metathesis. The RNAP‐inhibitory and antibacterial activities are presented. Structure–activity relationships indicate that the monocyclic keto‐ol form of ripostatin A is the active form of ripostatin A, that the ripostatin C5–C6 unsaturation is important for activity, and that C14 geminal difluorination of ripostatin B results in no loss of activity. F makes the difference: The introduction of a gem‐difluorine substitution into the antibiotic ripostatin B produced an analogue with full activity and increased stability (see scheme; IC50: half maximal inhibitory concentration). The synthesis features the application of a double Stille cross‐coupling/ring‐closing metathesis strategy. Several other ripostatin analogues also were prepared and evaluated.